Consequently, POLθ inhibition drives the expression of type I interferon response elements, including PD-L1, and increases CD8+ T-cell tumor infiltration and activation, as well as activation of antigen-presenting dendritic cells (DCs) in a paracrine fashion. This evidence concerns the gene CD8A and neoplasm.